0HS8:LSE:LSE-Caladrius Biosciences Inc. (USD)

COMMON STOCK | |

Last Closing

USD 2.59

Change

0.00 (0.00)%

Market Cap

N/A

Volume

529.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-20 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
0R2T:LSE Micron Technology Inc

-1.54 (-1.49%)

USD 9,223,372,036.85B
0R2F:LSE Wells Fargo & Company

+0.63 (+0.80%)

USD 9,223,372,036.85B
0R15:LSE SoftBank Group Corp.

-153.00 (-1.60%)

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

-49.28 (-0.43%)

USD 7,596.04B
0M69:LSE OTP Bank Nyrt

N/A

USD 5,014.80B
0R28:LSE Newmont Corp.

-1.71 (-3.57%)

USD 4,231.43B
0R2O:LSE Freeport-McMoRan Inc.

-0.87 (-2.22%)

USD 4,154.37B
0QYD:LSE Yum! Brands Inc.

+0.85 (+0.57%)

USD 4,109.92B
0QZ4:LSE Delta Air Lines Inc.

+0.15 (+0.24%)

USD 4,094.73B
0Y4Q:LSE Willis Towers Watson PLC

-0.06 (-0.02%)

USD 4,090.61B

ETFs Containing 0HS8:LSE

EATZ AdvisorShares Restaurant .. 5.38 % 0.00 %

-1.07 (-3.62%)

USD 3.58M
HAU-U:CA 3.45 % 0.00 %

N/A

N/A
RCD Invesco S&P 500® Equal W.. 2.40 % 0.40 %

+0.05 (+-3.62%)

N/A
BTAL AGFiQ U.S. Market Neutral.. 0.50 % 0.00 %

+0.30 (+-3.62%)

N/A
XDEW:F 0.24 % 0.00 %

N/A

N/A
XDEW:XETRA 0.24 % 0.00 %

N/A

N/A
RSP Invesco S&P 500® Equal W.. 0.00 % 0.20 %

-2.56 (-3.62%)

N/A
RXI iShares Global Consumer D.. 0.00 % 0.46 %

-2.70 (-3.62%)

N/A
XDEW:LSE Xtrackers S&P 500 Equal W.. 0.00 % 0.00 %

-0.03 (-3.62%)

N/A
XDWE:LSE Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

-12.50 (-3.62%)

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.09% N/A N/A 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.09% N/A N/A 11% F
Trailing 12 Months  
Capital Gain -15.77% N/A N/A 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -15.77% N/A N/A 17% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 111.55% N/A N/A 95% A
Dividend Return 111.55% N/A N/A 95% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 205.78% N/A N/A 10% F
Risk Adjusted Return 54.21% N/A N/A 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike